XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

FAIR VALUE MEASUREMENTS AND DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Disclosures [Abstract] |
Company's population of financial assets and liabilities subject to fair value measurements | The Company’s population of financial assets and liabilities subject to fair value measurements were as follows:
|  |  |  |  | Fair Value Measurements
| Condensed Consolidated Balance Sheets Classification |  |  |  | March 31, 2025
|  | Fair Value at |  | Using Fair Value Hierarchy
|  | March 31, 2025 |  | Level 1 |  | Level 2 |  | Level 3
Noncontrolling interest put | Noncontrolling interest |  | $ | 14.3 |  |  | $ | — |  |  | $ | 14.3 |  |  | $ | — |
Cross currency swaps | Other liabilities |  | $ | 135.7 |  |  | $ | — |  |  | $ | 135.7 |  |  | $ | — |
Interest rate swaps | Other liabilities |  | $ | 65.0 |  |  | $ | — |  |  | $ | 65.0 |  |  | $ | — |
Cash surrender value of life insurance policies | Other assets, net |  | $ | 101.3 |  |  | $ | — |  |  | $ | 101.3 |  |  | $ | — |
Deferred compensation asset | Other assets, net |  | $ | 40.6 |  |  | $ | — |  |  | $ | 40.6 |  |  | $ | — |
Deferred compensation liability | Other liabilities |  | $ | 134.0 |  |  | $ | — |  |  | $ | 134.0 |  |  | $ | — |
Contingent consideration | Accrued expenses and other/Other liabilities |  | $ | 34.8 |  |  | $ | — |  |  | $ | — |  |  | $ | 34.8 |
|  |  |  |  | Fair Value Measurements
| Condensed Consolidated Balance Sheets Classification |  |  |  | December 31, 2024
|  | Fair Value at |  | Using Fair Value Hierarchy
|  | December 31, 2024 |  | Level 1 |  | Level 2 |  | Level 3
Noncontrolling interest put | Noncontrolling interest |  | $ | 14.3 |  |  | $ | — |  |  | $ | 14.3 |  |  | $ | — |
Cross currency swaps | Other liabilities |  | $ | 142.7 |  |  | $ | — |  |  | $ | 142.7 |  |  | $ | — |
Interest rate swaps | Other liabilities |  | $ | 76.8 |  |  | $ | — |  |  | $ | 76.8 |  |  | $ | — |
Cash surrender value of life insurance policies | Other assets, net |  | $ | 102.1 |  |  | $ | — |  |  | $ | 102.1 |  |  | $ | — |
Deferred compensation asset | Other assets, net |  | $ | 35.7 |  |  | $ | — |  |  | $ | 35.7 |  |  | $ | — |
Deferred compensation liability | Other liabilities |  | $ | 132.5 |  |  | $ | — |  |  | $ | 132.5 |  |  | $ | — |
Contingent consideration | Accrued expenses and other/Other liabilities |  | $ | 10.8 |  |  | $ | — |  |  | $ | — |  |  | $ | 10.8 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation |
Fair Value Measurement of Level 3 Liabilities: |  | Contingent Consideration
Balance at December 31, 2024 |  | $ | 10.8 |
Additions |  | 24.0 |
Balance at March 31, 2025 |  | $ | 34.8 |
Derivative Instruments, Gain (Loss) [Table Text Block] | The table below provides information regarding the location and amount of pretax gains of derivatives designated in fair value hedging relationships:
|  | Amounts included in other comprehensive income
|  | Three Months Ended March 31,
|  | 2025 |  | 2024
Cross currency swaps |  | $ | 7.0 |  |  | $ | 17.0 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration